Susquehanna International Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Sell
83,623
-79,102
-49% -$1.59M ﹤0.01% 6868
2025
Q4
$3.81M Buy
162,725
+15,500
+11% +$336K 0.01% 4485
2025
Q3
$2.94M Sell
147,225
-337,598
-70% -$6.06M ﹤0.01% 5011
2025
Q2
$6.64M Buy
484,823
+392,798
+427% +$3.77M 0.01% 3480
2025
Q1
$1.02M Buy
92,025
+51,892
+129% +$553K ﹤0.01% 7222
2024
Q4
$427K Buy
40,133
+3,118
+8% +$37.3K ﹤0.01% 9056
2024
Q3
$470K Sell
37,015
-59,330
-62% -$881K ﹤0.01% 8600
2024
Q2
$1.62M Buy
96,345
+68,934
+251% +$981K ﹤0.01% 5504
2024
Q1
$411K Buy
27,411
+683
+3% +$11.2K ﹤0.01% 8968
2023
Q4
$401K Buy
26,728
+6,553
+32% +$85.1K ﹤0.01% 9175
2023
Q3
$283K Buy
20,175
+7,441
+58% +$119K ﹤0.01% 9484
2023
Q2
$132K Sell
12,734
-186,699
-94% -$2.06M ﹤0.01% 10702
2023
Q1
$1.84M Buy
199,433
+160,461
+412% +$1.48M ﹤0.01% 5311
2022
Q4
$346K Buy
+38,972
New +$369K ﹤0.01% 8753
2022
Q3
Hold
0
14367
2021
Q2
Sell
-14,580
Closed -$284K 13485
2021
Q1
$284K Sell
14,580
-566
-4% -$12K ﹤0.01% 10727
2020
Q4
$273K Sell
15,146
-23,150
-60% -$485K ﹤0.01% 9456
2020
Q3
$739K Sell
38,296
-48,411
-56% -$1.1M ﹤0.01% 6846
2020
Q2
$2.27M Sell
86,707
-6,403
-7% -$156K ﹤0.01% 4280
2020
Q1
$1.66M Sell
93,110
-9,335
-9% -$252K ﹤0.01% 4315
2019
Q4
$3.42M Buy
102,445
+47,916
+88% +$1.31M 0.01% 3496
2019
Q3
$1.3M Buy
54,529
+46,749
+601% +$1.53M ﹤0.01% 5134
2019
Q2
$280K Buy
+7,780
New +$287K ﹤0.01% 8459
2019
Q1
Hold
0
10552
2018
Q4
Sell
-5,141
Closed -$231K 10709
2018
Q3
$243K Buy
+5,141
New +$239K ﹤0.01% 7872

Other funds holding URGN